NCT06233565View on ClinicalTrials.gov

Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 9, 2024

Primary Completion Date

July 8, 2025

Study Completion Date

July 8, 2025

Conditions
Foot Injuries and DisordersAnkle Injuries and Disorders
Interventions
DRUG

0.9%sodium chloride

administration of 0.5ml/kg of 0,2% ropivacaine + 0.01ml/kg 0.9% sodium chloride for the popliteal nerve block

DRUG

Dexamethasone

administration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the popliteal nerve block

DRUG

Dexmedetomidine

administration of 0.5ml/kg of 0.2% ropivacaine with 0.1ug/kg Dexmedetomidine for the popliteal nerve block

Trial Locations (2)

61-701

Poznan University of Medical Sciences, Poznan

61-545

Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06233565 - Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery | Biotech Hunter | Biotech Hunter